Evogene (EVGN) Minority Interest (2018 - 2025)
Evogene (EVGN) posted Minority Interest of $12.1 million for Q4 2025, down 24.29% sequentially from $15.9 million in Q2 2025, and down 25.98% YoY from $16.3 million in Q4 2024.
Evogene (EVGN) Minority Interest (2018 - 2025) Analysis & Trends
Evogene has reported Minority Interest for 8 years, with the latest figure at $12.1 million in Q4 2025.
- Quarterly Minority Interest fell 25.98% year-over-year to $12.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.1 million (down 25.98% YoY) and the FY2025 annual result came in at $12.1 million, down 25.98% from the prior year.
- Minority Interest slipped to $12.1 million in Q4 2025 per EVGN's latest filing, from $15.9 million in the prior quarter.
- Over five years, Minority Interest peaked at $17.4 million in Q3 2023 and troughed at $6.4 million in Q1 2023.
- A 5-year average of $12.5 million and a median of $11.3 million in 2021 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2023 and 2024: Minority Interest slumped 30.37% in 2023, then soared 166.84% in 2024.
- Over 5 years, Minority Interest stood at $9.8 million in 2021, then fell by 29.76% to $6.9 million in 2022, then soared by 142.45% to $16.6 million in 2023, then retreated by 2.06% to $16.3 million in 2024, then slipped by 25.98% to $12.1 million in 2025.
- According to Business Quant data, Minority Interest over the past three periods registered $12.1 million, $15.9 million, and $16.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Evogene | 4.38 Mn | 4.38 Mn | 204,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.06 Mn |
| Jun 30, 2025 | 15.93 Mn |
| Dec 31, 2024 | 16.29 Mn |
| Sep 30, 2024 | 16.58 Mn |
| Jun 30, 2024 | 16.87 Mn |
| Mar 31, 2024 | 17.09 Mn |
| Dec 31, 2023 | 16.63 Mn |
| Sep 30, 2023 | 17.35 Mn |
| Jun 30, 2023 | 16.82 Mn |
| Mar 31, 2023 | 6.41 Mn |
| Dec 31, 2022 | 6.86 Mn |
| Sep 30, 2022 | 7.72 Mn |
| Jun 30, 2022 | 8.45 Mn |
| Mar 31, 2022 | 9.20 Mn |
| Dec 31, 2021 | 9.77 Mn |
| Sep 30, 2021 | 10.07 Mn |
| Jun 30, 2021 | 10.24 Mn |
| Mar 31, 2021 | 10.57 Mn |
| Dec 31, 2020 | 10.84 Mn |
| Sep 30, 2020 | 11.14 Mn |